These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21863207)

  • 21. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.
    Miles H; Johnson S; Amponsah-Afuwape S; Finch E; Leese M; Thornicroft G
    Psychiatr Serv; 2003 Apr; 54(4):554-61. PubMed ID: 12663845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system?
    Torrens M; Rossi PC; Martinez-Riera R; Martinez-Sanvisens D; Bulbena A
    Subst Use Misuse; 2012; 47(8-9):1005-14. PubMed ID: 22676568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms.
    Lechner WV; Dahne J; Chen KW; Pickover A; Richards JM; Daughters SB; Lejuez CW
    Drug Alcohol Depend; 2013 Jul; 131(1-2):78-84. PubMed ID: 23291208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical psychosis and pain in an English national sample: The role of common mental disorders.
    Koyanagi A; Stickley A; Haro JM
    Schizophr Res; 2016 Aug; 175(1-3):209-215. PubMed ID: 27156241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-occurring psychotic and addictive disorders: neurobiology and diagnosis.
    Ross S; Peselow E
    Clin Neuropharmacol; 2012; 35(5):235-43. PubMed ID: 22986797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance abuse in first-episode bipolar I disorder: indications for early intervention.
    Baethge C; Baldessarini RJ; Khalsa HM; Hennen J; Salvatore P; Tohen M
    Am J Psychiatry; 2005 May; 162(5):1008-10. PubMed ID: 15863809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Beavan A; McGorry P; Yung AR
    Am J Psychiatry; 2015 Mar; 172(3):249-58. PubMed ID: 25727537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder.
    Cosoff SJ; Hafner RJ
    Aust N Z J Psychiatry; 1998 Feb; 32(1):67-72. PubMed ID: 9565185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manic symptoms and impulsivity during bipolar depressive episodes.
    Swann AC; Moeller FG; Steinberg JL; Schneider L; Barratt ES; Dougherty DM
    Bipolar Disord; 2007 May; 9(3):206-12. PubMed ID: 17430294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Course, remission and recovery in patients with severe psychotic disorders with or without comorbid substance use disorders: Long-term outcome in evidence-based integrated care (ACCESS II study).
    Ruppelt F; Rohenkohl A; Kraft V; Schöttle D; Schröter R; Gaianigo J; Werkle N; Daubmann A; Karow A; Lambert M
    Schizophr Res; 2020 Aug; 222():437-443. PubMed ID: 32507378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
    Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
    Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.
    Fatseas M; Serre F; Swendsen J; Auriacombe M
    Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, patterns, associated factors and severity of substance use among psychotic patients in southern Thailand.
    Tantirangsee N; Assanangkornchai S
    Asian J Psychiatr; 2015 Feb; 13():30-7. PubMed ID: 25515268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    Bauer MS; Altshuler L; Evans DR; Beresford T; Williford WO; Hauger R;
    J Affect Disord; 2005 Apr; 85(3):301-15. PubMed ID: 15780700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.
    Elbogen EB; Swanson JW; Swartz MS; Van Dorn R
    J Nerv Ment Dis; 2005 Oct; 193(10):673-9. PubMed ID: 16208163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbid anxiety in patients with psychosis.
    Dernovsek MZ; Sprah L
    Psychiatr Danub; 2009 Sep; 21 Suppl 1():43-50. PubMed ID: 19789484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.